Latest & greatest articles for asthma

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on asthma or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on asthma and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for asthma

61. Omalizumab to Prevent Exacerbations in Children and Adolescents with Moderate-to-Severe Allergic Asthma: An Overview of Systematic Reviews Full Text available with Trip Pro

Omalizumab to Prevent Exacerbations in Children and Adolescents with Moderate-to-Severe Allergic Asthma: An Overview of Systematic Reviews Omalizumab to Prevent Exacerbations in Children and Adolescents with Moderate-to-Severe Allergic Asthma: An Overview of Systematic Reviews | B52. PEDIATRIC ASTHMA AND ALLERGY Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: B52. PEDIATRIC ASTHMA (...) AND ALLERGY > > > Omalizumab to Prevent Exacerbations in Children and Adolescents with Moderate-to-Severe Allergic Asthma: An Overview of Systematic Reviews Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A3702 Omalizumab to Prevent Exacerbations in Children and Adolescents with Moderate-to-Severe Allergic Asthma: An Overview of Systematic Reviews x X. Zhang , x L. Huang , x Y. Zhang , x H. Zhang , x Y. Feng , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services

2020 B52. PEDIATRIC ASTHMA AND ALLERGY

62. Association of metformin use with asthma exacerbation in patients with concurrent asthma and diabetes: a systematic review and meta-analysis of observational studies Full Text available with Trip Pro

Association of metformin use with asthma exacerbation in patients with concurrent asthma and diabetes: a systematic review and meta-analysis of observational studies Inplasy Protocol 232 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 International Platform of Registered Systematic Review and Meta-analysis Protocols

63. Targeting treatable traits in severe asthma: a randomised controlled trial

Targeting treatable traits in severe asthma: a randomised controlled trial Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library of Medicine National Center (...) Mar 5;55(3):1901509. doi: 10.1183/13993003.01509-2019. Print 2020 Mar. Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial , , , , , Affiliations Expand Affiliations 1 National Health and Medical Research Council, Centre of Excellence in Severe Asthma, Newcastle, Australia Vanessa.McDonald@newcastle.edu.au. 2 Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, Australia. 3 Hunter Medical Research Institute, Newcastle, Australia. 4 Dept

2020 EvidenceUpdates

64. Asthma and children: diagnosis and treatment

Asthma and children: diagnosis and treatment Asthma and children: diagnosis and treatment - NPS MedicineWise Log In Menu During the COVID-19 pandemic, you need to continue to take your usual medicines and stay as healthy as possible. Here is some important information for everyone to keep in mind. Featured topics 30 Mar 2020 30 Mar 2020 30 Mar 2020 Featured article Information for consumers about medicines and COVID-19 | Updated regularly as the situation changes. Keep a medicines list The more (...) February 2020 8 January 2020 Featured topic 20 years of helping Australians make better decisions about medicines, medical tests and other health technologies Partner with us Latest projects Search Search Search Search POPULAR Log in Log in All fields are required Email address* Password* Log in Asthma and children: diagnosis and treatment Asthma is a chronic disease that requires accurate diagnosis, regular treatment and review. For consumers , check out Asthma diagnosis and treatment during the COVID

2020 National Prescribing Service Limited (Australia)

65. Budesonide / formoterol fumarate dihydrate - asthma

Budesonide / formoterol fumarate dihydrate - asthma Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. EMA/118969/2020 EMEA/H/C/004882 Budesonide/Formoterol Teva Pharma B.V (...) . (budesonide/ formoterol) An overview of Budesonide/Formoterol Teva Pharma B.V. and why it is authorised in the EU What is Budesonide/Formoterol Teva Pharma B.V. and what is it used for? Budesonide/Formoterol Teva Pharma B.V. is a medicine used for the treatment of asthma in adults for whom a combination product is considered appropriate. It can be used in patients: • whose disease is not adequately controlled by treatment with other asthma medicines called corticosteroids and ‘short-acting beta-2 agonists

2020 European Medicines Agency - EPARs

66. Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases

Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases Technical Brief Number 34 RTechnical Brief Number 34 Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases Prepared for: Agency for Healthcare Research and Quality (...) -EF March 2020 ii Key Messages Purpose of Technical Brief To explore and describe the state of the evidence on community health worker certification and its relationship with community health worker outcomes (such as recruitment, retention, and employment stability) and outcomes for people with asthma and other selected chronic illnesses. Key messages • A number of States are initiating efforts to certify community health workers practicing in their States. • We did not find any studies evaluating

2020 Effective Health Care Program (AHRQ)

67. Breathing exercises for adults with asthma. (Abstract)

Breathing exercises for adults with asthma. Breathing exercises have been widely used worldwide as a non-pharmacological therapy to treat people with asthma. Breathing exercises aim to control the symptoms of asthma and can be performed as the Papworth Method, the Buteyko breathing technique, yogic breathing, deep diaphragmatic breathing or any other similar intervention that manipulates the breathing pattern. The training of breathing usually focuses on tidal and minute volume and encourages (...) . The most recent literature search was on 4 April 2019.We included randomised controlled trials of breathing exercises in adults with asthma compared with a control group receiving asthma education or, alternatively, with no active control group.Two review authors independently assessed study quality and extracted data. We used Review Manager 5 software for data analysis based on the random-effects model. We expressed continuous outcomes as mean differences (MDs) with confidence intervals (CIs) of 95

2020 Cochrane

68. Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. Full Text available with Trip Pro

Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. We previously reported the results of a trial of prenatal vitamin D supplementation to prevent asthma and recurrent wheeze in young children, which suggested that supplementation provided a protective effect at the age of 3 years. We followed the children through the age of 6 years to determine the course of asthma and recurrent wheeze.In this follow-up study, investigators and participants remained unaware (...) of the treatment assignments through the children's sixth birthday. We aimed to determine whether, when maternal levels of 25-hydroxyvitamin D were taken into account, children born to mothers who had received 4400 IU of vitamin D3 per day during pregnancy (vitamin D group) would have a lower incidence of asthma and recurrent wheeze at the age of 6 years than would those born to mothers who had received 400 IU of vitamin D3 per day (control group). Time-to-event methods were used to compare the treatment

2020 NEJM

69. Asthma: School-Based Self-Management Interventions for Children and Adolescents with Asthma

Asthma: School-Based Self-Management Interventions for Children and Adolescents with Asthma Asthma: School-Based Self-Management | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) July 2019 Audience Adolescents and Young Adults Children/Infants Setting School Strategy Case Management Counseling (...) Health Education Organizational Changes This webpage summarizes information available in the CPSTF Finding and Rationale Statement. Asthma: School-Based Self-Management Interventions for Children and Adolescents with Asthma Tabs Snapshot Summary of CPSTF Finding The school-based asthma self-management interventions to reduce hospitalizations and emergency room visits among children and adolescents with asthma. Evidence shows interventions are effective when delivered by trained school staff, nurses

2020 Community Preventive Services Task Force

70. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. (Abstract)

Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. Asthma is a disease of reversible airflow obstruction characterised clinically by wheezing, shortness of breath, and coughing. Increases in airway type 2 cytokine activity, including interleukin-4 (IL-4), IL-5, and IL-13, are now established biological mechanisms in asthma. Inhaled corticosteroids have been the foundation for asthma treatment, in a large part because they decrease airway type 2 inflammation (...) . However, inhaled or systemic corticosteroids are ineffective treatments in many patients with asthma and few treatment options exist for patients with steroid resistant asthma. Although mechanisms for corticosteroid refractory asthma are likely to be numerous, the development of a new class of biologic agents that target airway type 2 inflammation has provided a new model for treating some patients with corticosteroid refractory asthma. The objective of this Therapeutic paper is to summarise the new

2020 Lancet

71. Risk of asthma in children treated with paracetamol versus ibuprofen: A systematic review and meta-analysis of randomised controlled trials Full Text available with Trip Pro

Risk of asthma in children treated with paracetamol versus ibuprofen: A systematic review and meta-analysis of randomised controlled trials Risk of asthma in children treated with paracetamol versus ibuprofen: A systematic review and meta-analysis of randomised controlled trials | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research (...) Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Risk of asthma in children treated with paracetamol versus ibuprofen: A systematic review and meta-analysis of randomised controlled trials Mohamed Sherbash, Luis Furuya-Kanamori, Joanne Daghfal Nader, Lukman Thalib Mohamed

2020 Research Square

72. Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: A meta-analysis based on 24 studies Full Text available with Trip Pro

Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: A meta-analysis based on 24 studies Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: A meta-analysis based on 24 studies | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting (...) of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: A meta-analysis based on 24 studies Danyal Imani, Mohammad Masoud Eslami, Gholamreza Anani Sarab, Mansur Aliyu, Bahman Razi, Ramazan rezaei Danyal Imani Tehran University of Medical Sciences Mohammad Masoud Eslami Tarbiat Modares University

2020 Research Square

73. Using Inhaled Steroids in Asthma durIng the COVID-19 Outbreak Full Text available with Trip Pro

Using Inhaled Steroids in Asthma durIng the COVID-19 Outbreak Inhaled Steroids in Asthma durIng the COVID-19 Outbreak - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Inhaled Steroids in Asthma durIng the COVID-19 Outbreak Jamie Hartmann-Boyce, Richard Hobbs Are inhaled steroids in asthma OK to use or should you discontinue them? Verdict : There is no evidence of a relationship between the use of inhaled (...) corticosteroids and COVID-19 infection at present. Inhaled corticosteroids are generally considered a for controlling asthma symptoms. Evidence from a of seven randomized controlled trials found that discontinuing inhaled corticosteroids in people with stable asthma more than doubled the risk of asthma exacerbation (RR 2.35, 95% CI 1.88 to 2.92, mean follow-up 27 weeks). Inhaled corticosteroids, when taken as prescribed, would reduce the risk of an asthma attack being triggered by a respiratory virus

2020 Oxford COVID-19 Evidence Service

74. Paediatric asthma and COVID-19

Paediatric asthma and COVID-19 Paediatric asthma and COVID-19Paediatric asthma and COVID-19 | Canadian Paediatric Society A home for paediatricians. A voice for children and youth. Current: Paediatric asthma and… Practice Point Paediatric asthma and COVID-19 Posted: Apr 1 2020 The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our . Principal author(s) Elissa Abrams, Geert (...) ’t Jong, Connie Yang, Canadian Paediatric Society, , , COVID-19 is a predominantly respiratory infection, and there are concerns regarding the effects of this virus on children and youth with asthma. No evidence to date suggests that young people with asthma are at increased risk for COVID-19 infection [ ] [ ] . However, there is a theoretical possibility that a child or youth with asthma infected with COVID-19 could experience an asthma exacerbation and serious morbidity due to combined effects

2020 Canadian Paediatric Society

75. COVID-19 rapid guideline: severe asthma

COVID-19 rapid guideline: severe asthma COVID-19 rapid guideline: severe asthma NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng166 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals (...) and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: severe asthma (NG166) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 11Contents Contents Overview 4 1 Communicating with patients and minimising risk 5 2 Investigations 7 3 Treatment 8

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

76. Child and Adolescent Asthma Guidelines

Child and Adolescent Asthma Guidelines 10 NZMJ 1 December 2017, Vol 130 No 1466 ISSN 1175-8716 © NZMA www.nzma.org.nz/journal Asthma and Respiratory Foundation NZ child and adolescent asthma guidelines: a quick reference guide Innes Asher, David McNamara, Cheryl Davies, Teresa Demetriou, Theresa Fleming, Matire Harwood, Lorraine Hetaraka-Stevens, Tristram Ingham, John Kristiansen, Jim Reid, Debbie Rickard, Debbie Ryan ABSTRACT The purpose of the New Zealand Child and adolescent asthma (...) guidelines: a quick reference guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of asthma in children and adolescents in New Zealand, with the aim of improving outcomes and reducing inequities. The intended users are health professionals responsible for delivering asthma care in the community and hospital emergency department settings, and those responsible for the training of such health professionals. Abbreviations: FEV 1 Forced

2020 Asthma and Respiratory Foundation NZ

77. Asthma and COVID-19: risks and management considerations

Asthma and COVID-19: risks and management considerations Asthma and COVID-19: risks and management considerations - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Asthma and COVID-19: risks and management considerations May 28, 2020 Jamie Hartmann-Boyce 1 Afolarin Otunla 2 Jonny Drake 2 Jana Suklan 3 Ella Schofield 2 Jade Kinton 2 James Gunnell 2 Andrew Menzies-Gow 4 Matt Inada-Kim 5 Richard Hobbs 1 (...) if people with asthma are at increased risk of contracting COVID-19 or of worse outcomes from COVID-19 infection. The evidence available is limited with some sources suggesting an underrepresentation of PWA in hospitalised cases, and others showing an increased risk of worse outcomes in PWA which may be associated with disease severity. Consensus broadly holds that asthma medications should be continued as usual. Asthma care may be disrupted during the pandemic; self-management and remote interventions

2020 Oxford COVID-19 Evidence Service

78. The impact of CRTH2 antagonist OC 000459 on pulmonary function of asthma patients: a meta-analysis of randomized controlled trials Full Text available with Trip Pro

The impact of CRTH2 antagonist OC 000459 on pulmonary function of asthma patients: a meta-analysis of randomized controlled trials The impact of CRTH2 antagonist OC 000459 on pulmonary function of asthma patients: a meta-analysis of randomized controlled trials Sign in eISSN: 2299-0046 ISSN: 1642-395X Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii Search Share: Copy url: Share: abstract: Original paper The impact of CRTH2 antagonist OC 000459 on pulmonary function (...) of asthma patients: a meta-analysis of randomized controlled trials Meng Tang , Yan Zhang , Ying Chen Adv Dermatol Allergol DOI: Online publish date: 2020/01/31 Get citation AMA Tang M, Zhang Y, Chen Y. The impact of CRTH2 antagonist OC 000459 on pulmonary function of asthma patients: a meta-analysis of randomized controlled trials. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. 2020. doi:10.5114/ada.2020.92296. APA Tang, M., Zhang, Y., & Chen, Y. (2020). The impact of CRTH2

2020 Advances in Dermatology and Allergology

79. The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trialsb Full Text available with Trip Pro

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trialsb The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trialsb Sign in eISSN: 2299-0046 ISSN: 1642-395X Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii Search Share: Copy url: Share: abstract: Original paper (...) The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trialsb Xiaofen Jin , Lianfang Wu , Ji Wang , Malong Feng Adv Dermatol Allergol DOI: Online publish date: 2020/01/31 Get citation AMA Jin X, Wu L, Wang J, Feng M. The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trialsb. Postępy Dermatologii i

2020 Advances in Dermatology and Allergology

80. eHealth Only Interventions and Blended Interventions to Support Self-management in Adolescents with Asthma: A Systematic Review Full Text available with Trip Pro

eHealth Only Interventions and Blended Interventions to Support Self-management in Adolescents with Asthma: A Systematic Review Redirecting

2020 Clinical eHealth